Navigation Links
BESAFE Conference in Manchester: Working towards a brighter future for biodiversity
Date:2/22/2013

A joint BESAFE BIOMOT meeting is held between 20-22 February in Manchester, UK to map the progress and development of the projects and set the agenda for the future. Alongside reports from the last 16 months, this meeting will focus on the forthcoming case study work. A special session of the workshop will be designated to the interface between the two projects to outline the common objectives and directions for possible cooperation.

The general aim of the FP7 funded project BESAFE is to provide a framework that summarises the impact of alternative arguments used to explain the importance of biodiversity protection, and to make this framework easily accessible and usable through a publicly accessible database and associated toolkit. BESAFE aims at innovating and improving biodiversity protection, through demonstrating its value through applying ecological, socio-economic, spatial and temporal contexts.

The BIOMOT project (MOTivational strength of ecosystem services and alternative ways to express the value of BIOdiversity) addresses the same problem of building and sustaining motivation to act for biodiversity. BIOMOT undertakes empirical research in seven European countries to examine the potential or observed effectiveness of alternative ways to argue the case for swift and effective action to prevent further degradation of the natural world.

As the two project coordinators put it: "BESAFE and BIOMOT are different. The first project is looking at arguments at work, the second at why people act for biodiversity. They are therefore quite complementary. Yet they have a common drive to develop a new, non-economic language to speak about nature in policy making. On that basis they also share some of the case study work".


'/>"/>

Contact: Rob Bugter
Rob.Bugter@wur.nl
31-317-486-067
Pensoft Publishers
Source:Eurekalert  

Related biology news :

1. SMU conference aims to spur development of geothermal production in oil and gas fields
2. AFCEAs Homeland Security Conference Returns To Washington, D.C.
3. Conference on securing the future supply of food: Challenges and opportunities
4. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
5. Early Bird Conference Registrations Expiring This Friday
6. Sustaining Coastal Cities Conference at Northeastern University
7. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
8. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
9. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
10. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
11. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BESAFE Conference in Manchester: Working towards a brighter future for biodiversity
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
Breaking Biology Technology: